Figure 2
Haemotoxylin and eosin (HE) stained liver section of vehicle control animals showing polyhedral hepatocytes (H), central vein (CV) and portal vein (PV) (2a); rats administered CCl4 showing altered histoarchitecture characterized by fatty changes i.e. steatosis [1], inflammatory bridges [2] and vascular bridges [3] 2(b); S-SLNs treated rats showing mild steatosis [4] and medium portal inflammation [5] 2(c); FS treated rats showing medium steatosis [6], high inflammation [7]; SILY treated rats showing medium steatosis [8] and inflammation [9] 2(e); and untreated SR group showing altered histoarchitecture with high occurrence of steatosis [10] and inflammation [11] 2(f). Representative views of each group are presented at 200X magnification.